Intensity Therapeutics, Inc.
INTS
$0.282
-$0.009-3.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.20% | -5.22% | 9.45% | 29.33% | -7.99% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.62% | -49.66% | 70.10% | -13.74% | -48.58% |
| Change in Net Operating Assets | -162.16% | 352.62% | 62.73% | -708.75% | 117.32% |
| Cash from Operations | -23.48% | 25.45% | 32.83% | 5.74% | 3.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 51,766.67% | -100.18% |
| Cash from Investing | -- | -- | -100.00% | 51,766.67% | -100.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,255.36% | -88.68% | 515.56% | 16,400.00% | -62.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5,388.24% | 97.02% | -596.34% | -- | -- |
| Cash from Financing | 1,041.16% | -86.75% | 499.52% | 13,666.67% | -62.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 177.48% | -765.10% | 58.17% | 89.12% | -284.06% |